About BioLok
BioLok is a company based in Osaka (Japan) founded in 1987 was acquired by HealthpointCapital in September 2006. BioLok has raised $3.75 million across 2 funding rounds from investors including HHS, Radius Ventures and HealthpointCapital. BioLok operates in a competitive market with competitors including Convergent Dental, Neoss, Keystone Dental, Osstem and BioHorizons, among others.
- Headquarter Osaka, Japan
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.75 M (USD)
in 2 rounds
-
Latest Funding Round
$3.75 M (USD), Series A
Mar 03, 2005
-
Investors
HHS
& 2 more
-
Employee Count
Not available
-
Acquired by
HealthpointCapital
(Sep 08, 2006)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of BioLok
BioLok has successfully raised a total of $3.75M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $3.75 million completed in March 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in BioLok
BioLok has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, Radius Ventures and HealthpointCapital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
HealthpointCapital is focused on private equity in musculoskeletal healthcare.
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for BioLok
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BioLok
Investment portfolio details for BioLok
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BioLok
Detailed financials for BioLok
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biolok Comparisons
Peer comparison for BioLok
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BioLok
BioLok operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Convergent Dental, Neoss, Keystone Dental, Osstem and BioHorizons, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Dental CO2 laser for soft and hard tissue application
|
|
| Locked | Locked | Locked |
Dental implant solutions are provided for patients and professionals.
|
|
| Locked | Locked | Locked |
Dental implants and biomaterials are developed by Keystone Dental.
|
|
| Locked | Locked | Locked |
Dental implants and kits are manufactured and distributed by Osstem.
|
|
| Locked | Locked | Locked |
Dental implant technologies and tissue regeneration products are developed.
|
|
| Locked | Locked | Locked |
Overdenture attachments and dental implants are developed and distributed.
|
Detailed competitors of BioLok
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biolok
Complete news archive for BioLok
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioLok
BioLok was founded in 1987 and raised its 1st funding round 16 years after it was founded.
BioLok is headquartered in Osaka, Japan. It is registered at Osaka, Osaka Prefecture, Japan.
Bruce L Hollander is the current CEO of BioLok.
BioLok is a funded company, having raised a total of $3.75M across 2 funding rounds to date.
BioLok International (OTCBB: BLLI) develops and market products for the dental implant and tissue regeneration markets. BioLok is the worldwide manufacturer and distributor of the BioLok Precision Dental Implant System. In 2006, Biolok was acquired by Healthpoint Capital for 35M.
BioLok's top competitors include Neoss, Keystone Dental and Nobel Biocare.
BioLok has 3 investors. Key investors include HHS, Radius Ventures, and HealthpointCapital.